Genetics of Congenital Heart Disease
Genetic Testing of Individuals and Families With Congenital Heart Disease
Nationwide Children's Hospital
5,000 participants
Dec 1, 2009
OBSERVATIONAL
Conditions
Summary
Congenital heart disease (CHD) is the most common type of birth defect but the cause for the majority of cardiac birth defects remains unknown. Numerous epidemiologic studies have demonstrated evidence that genetic factors likely play a contributory, if not causative, role in CHD. While numerous genes have been identified by us and other investigators using traditional genetic approaches, these genes account for a minority of the non-syndromic CHDs. Therefore, we are now utilizing whole genome sequencing (WGS), with the addition of more traditional genetic techniques such as chromosomal microarray or traditional linkage analysis, to identify genetic causes of familial and isolated CHD. With WGS we are able to sequence all of the genetic material of an individual and apply different data analysis techniques based on whether we are analyzing a multiplex family or a cohort of trios (mother, father and child with CHD) with a specific isolated CHD. Therefore, WGS is a robust method for identification of novel genetic causes of CHD which will have important diagnostic and therapeutic consequences for these children.
Eligibility
Inclusion Criteria1
- Subjects must have a diagnosis of Congenital Heart Disease or be related to individuals with Congenital Heart Disease.
Exclusion Criteria1
- Healthy individuals unrelated to those with Congenital Heart Disease
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Blood sample collection for direct sequencing, microarray, single nucleotide polymorphism, whole-genome array comparative genomic hybridization DNA analyses, and/or whole exome or genome sequencing.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01192048